- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04766125
Psychological Factors in Cardiac Surgery
April 3, 2025 updated by: University of Aarhus
The study investigates the effect of adverse event information on adverse event occurrence in patients undergoing elective cardiac surgery in a two-armed, randomized study.
One group will receive standard information about adverse events; the second group will receive a standardised elaboration of the standard information.
Hypothesis: Elaborated information about adverse events will increase adverse event occurrence, mediated by expectations and anxiety, and moderated by coping style.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
If quality assessment indicates that the protocol was not followed adequately, participants will be excluded from data analysis.
Study Type
Interventional
Enrollment (Actual)
103
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Aarhus University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults (18 and older) undergoing elective cardiac surgery at the Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital
Exclusion Criteria:
- Patients who have previously had cardiac surgery
- Cardiac surgery with deep hypothermia (<32 degrees Celsius)
- Acute surgery
- Patients with psychiatric or neurological disease who are unable to collaborate with the study protocol
- Patients who do not speak/read Danish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Standard adverse event information
|
All patients have access to the standard material about adverse events related to the surgery.
One arm will additionally receive elaborated adverse event information from a nurse and a surgeon
|
|
Other: Elaborated adverse event information
|
All patients have access to the standard material about adverse events related to the surgery.
One arm will additionally receive elaborated adverse event information from a nurse and a surgeon
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of adverse events
Time Frame: Assessed on day four
|
Assessed on day four
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of adverse events
Time Frame: Assessed on day 30, 90, and 180
|
Assessed on day 30, 90, and 180
|
|
Intensity of experienced adverse events
Time Frame: Assessed on day four, 30, 90, and 180
|
Assessed on day four, 30, 90, and 180
|
|
Hospital readmission
Time Frame: Assessed on day 180
|
Assessed on day 180
|
|
Occurrence of specific adverse events
Time Frame: Assessed on day four, 30, 90, and 180
|
Assessed on day four, 30, 90, and 180
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mette Sieg, University of Aarhus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 18, 2021
Primary Completion (Actual)
December 15, 2023
Study Completion (Actual)
June 12, 2024
Study Registration Dates
First Submitted
February 18, 2021
First Submitted That Met QC Criteria
February 18, 2021
First Posted (Actual)
February 23, 2021
Study Record Updates
Last Update Posted (Actual)
April 6, 2025
Last Update Submitted That Met QC Criteria
April 3, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- AUPsych
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Conditions
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
University of Maryland, BaltimoreCSL BehringTerminatedHeart Failure,Congestive | Heart Disease End StageUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
XVIVO PerfusionRecruitingHeart Failure | Transplant; Failure, Heart | Heart TransplantUnited States
-
Nantes University HospitalDirectorate of Health Care SupplyRecruitingHeart Diseases | Heart Failure | Heart Valve DiseasesFrance
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure, CongestiveUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Heart Failure, Congestive
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Heart Failure, Congestive
Clinical Trials on Adverse event information
-
Agency for Healthcare Research and Quality (AHRQ)CompletedImpact of Electronic Prescribing on Medication SafetyUnited States
-
Tata Medical CenterSuspendedGastrointestinal CancerIndia
-
Hospices Civils de LyonRecruiting
-
Research Unit Of General Practice, CopenhagenUniversity College Absalon; The Storm P. Museum; EGV Foundation; Danish Agency...UnknownQuality of Life | Loneliness | Social IsolationDenmark
-
RoCompletedErectile Dysfunction | Telemedicine | Internet-based Intervention | Online Intervention | Web-based InterventionUnited States
-
Baylor College of MedicineUnited States Department of DefenseTerminatedUrinary Tract InfectionUnited States
-
Peking Union Medical College HospitalNot yet recruiting
-
Victory Nutrition International, Inc.RecruitingBody Weight ChangesUnited States
-
Vireo Systems, Inc.Princeton Consumer ResearchCompletedBioavailability and AUCUnited States
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed